Cash Flow Aurinia Pharmaceuticals, Inc. Cash flow Statement
Figures in Million
Consolidated Cash Flow Results
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
No of Months
12
12
12
12
12
12
Profit Before Tax
7.00
-77.00
-106.00
-180.00
-102.00
-88.00
Adjustment
0.00
0.00
0.00
0.00
0.00
0.00
Changes In working Capital
5.00
-5.00
-6.00
-21.00
4.00
2.00
Cash Flow after changes in Working Capital
0.00
0.00
0.00
0.00
0.00
0.00
Cash Flow from Operating Activities
44.00
-33.00
-79.00
-157.00
-69.00
-63.00
Cash Flow from Investing Activities
39.00
-6.00
-60.00
-103.00
-158.00
7.00
Cash Flow from Financing Activities
-49.00
-5.00
2.00
221.00
194.00
243.00
Net Cash Inflow / Outflow
34.00
-45.00
-137.00
-40.00
-33.00
188.00
Opening Cash & Cash Equivalents
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent of Subsidiaries under liquidations
0.00
0.00
0.00
0.00
0.00
0.00
Translation adjustment on reserves / op cash balances foreign subsidiaries
0.00
0.00
0.00
0.00
0.00
0.00
Effect of Foreign Exchange Fluctuations
0.00
0.00
0.00
0.00
0.00
0.00
Closing Cash & Cash Equivalent
0.00
0.00
0.00
0.00
0.00
0.00
Figures in USD Million
Seasonal companies are compared with the same quarter last year
Seasonal companies are compared with the same quarter last year
Compare Cash Flow Results of Aurinia Pharmaceuticals, Inc.
Figures in Million
consolidated Cash Flow Results
Change(USD)
Change(%)
Profit Before Tax
7.44800000000859
-375.005
382.00
101.99%
Adjustment
0
0
0.00
0.00%
Changes In working Capital
5.44800000000628
-122.556
127.00
104.45%
Cash Flow after changes in Working Capital
0
0
0.00
0.00%
Cash Flow from Operating Activities
44.3880000000512
-352.977
396.00
112.58%
Cash Flow from Investing Activities
39.2620000000453
-96.411
135.00
140.72%
Cash Flow from Financing Activities
-49.0920000000566
390.664
-439.00
-112.57%
Net Cash Inflow / Outflow
34.5580000000399
-59.265
93.00
158.31%
Opening Cash & Cash Equivalents
0
0
0.00
0.00%
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0
0
0.00
0.00%
Cash & Cash Equivalent of Subsidiaries under liquidations
0
0
0.00
0.00%
Translation adjustment on reserves / op cash balances foreign subsidiaries
0
0
0.00
0.00%
Effect of Foreign Exchange Fluctuations
0
-0.541
0.00
100.00%
Closing Cash & Cash Equivalent
0
0
0.00
0.00%
Cash Flow - Snapshot (Consolidated) - Dec'24
YoY Growth in year ended Dec 2024 is 232.66% vs 57.93% in Dec 2023
Dec'24
Dec'23
Change(%)
Cash Flow from Operating Activities
44.39
-33.46
232.66%
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
